52 results
DEFM14A
KDNY
Chinook Therapeutics Inc
10 Jul 23
Proxy related to merger
4:01pm
be consummated in a timely and orderly manner as a result of a number of factors, including: (1) the business reputation and significant financial … on Centerview’s reputation and experience. Centerview is an internationally recognized investment banking firm that has substantial experience
PREM14A
KDNY
Chinook Therapeutics Inc
27 Jun 23
Preliminary proxy related to merger
4:02pm
of factors, including: (1) the business reputation and significant financial resources of Novartis and intention of Novartis to consummate the Merger; (2 … Centerview as its financial advisor in connection with the Transaction based on Centerview’s reputation and experience. Centerview is an internationally
DEFA14A
KDNY
Chinook Therapeutics Inc
12 Jun 23
Additional proxy soliciting materials
7:05am
provider of national reputation) to pay, as soon as reasonably practicable following the date on which the Milestone Achievement Notice has been … , appoint a qualified successor Rights Agent who shall be a stock transfer agent of national reputation or the corporate trust department
8-K
EX-2.1
KDNY
Chinook Therapeutics Inc
12 Jun 23
Chinook Therapeutics Enters into Agreement to be Acquired by Novartis AG
7:00am
of national reputation) to pay, as soon as reasonably practicable following the date on which the Milestone Achievement Notice has been delivered to the Rights … a qualified successor Rights Agent who shall be a stock transfer agent of national reputation or the corporate trust department of a commercial bank
424B3
iqcs2yau45tz9abo
26 Aug 20
Prospectus supplement
4:06pm
S-4/A
lpjtcdl
24 Aug 20
Registration of securities issued in business combination transactions (amended)
6:10am
S-4
kvjt5tq
22 Jul 20
Registration of securities issued in business combination transactions
12:00am